SCHEMBL14872162

SCHEMBL14872162

CC(=S)Nc1ccc(N)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R38 P59533 2/20 0.60
MAPT P10636 3/20 0.57
KMT2A Q03164 3/20 0.57
RAB9A P51151 2/20 0.57
MEN1 O00255 2/20 0.57
PKM P14618 2/20 0.48
CYP2C19 P33261 2/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
APEX1 P27695 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
ALDH1A1 P00352 4/20 0.45
GAA P10253 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
ALOX12 P18054 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14511451 0.87 TAS2R38 (0.75) TAS2R38MAPTKMT2AMEN1CYP2C19
SCHEMBL728343 0.83 ALDH1A1 (0.62) TAS2R38MAPTKMT2ARAB9AMEN1
SCHEMBL11550071 0.79 MAPT (0.67) MAPTKMT2ARAB9AMEN1PKM
SCHEMBL13693551 0.79 MAPT (0.62) TAS2R38MAPTCYP2C19LMNAALDH1A1
SCHEMBL14872243 0.78 TAS2R38 (0.62) TAS2R38MAPTKMT2AMEN1CYP2C19
SCHEMBL863133 0.78 TAS2R38 (0.62) TAS2R38MAPTKMT2ARAB9AMEN1
SCHEMBL8705118 0.78 GAA (0.65) TAS2R38MAPTKMT2ARAB9AMEN1
SCHEMBL11738124 0.76 MEN1 (0.62) TAS2R38MAPTKMT2AMEN1LMNA
SCHEMBL12973183 0.76 MAPT (0.54) MAPTKMT2ARAB9AMEN1PKM
SCHEMBL21985779 0.76 TAS2R38 (0.60) TAS2R38MAPTKMT2AMEN1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103140512-B Polymer-conjugated MetAP2 inhibitors and methods of treatment using the same 辛德弗雷克斯公司 2017-03-01 CN disclosed
US-8945927-B2 Polymers for delivering molecules of interest UNIVERSITE DE STRASBOURG (FR) 2015-02-03 US disclosed
US-20130096177-A1 POLYMERS FOR DELIVERING MOLECULES OF INTEREST CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096177-A1 POLYMERS FOR DELIVERING MOLECULES OF INTEREST PHAX, CD44, SNRPE TAS2R38 4282/4885MAPT 1493/4885KMT2A 2996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.